Abstract
Objective: We evaluated the efficacy of a temporarily placed porous catheter with continuous
application of a local anaesthetic (ON~Q® by I-Flow-Corp., Lake Forest, CA, USA) post
mastectomy vs. patients without this device regarding postoperative need for opioid
medication.
Material and Methods: At Fayette Medical Center, Alabama, a retrospective evaluation of all consecutive
mastectomies (n=49) within a five-year-period from 1/1997-12/2001 and statistical
analysis regarding postoperative need for opioids was performed. The ON~Q pain management
pump with continuous 0.25 % Sensorcaine® (Bupivacaine and Epinephrine) application
for about 72 h (n=22) was compared vs. a control group without pain management pump
(n=27).
Results: There were no statistical significant differences regarding patient demographics
in both groups. Patients in the ON~Q group with no need of postoperative opioid pain
medication were: 18.2 vs. 3.7 % (P=0.1), no need for opioids after postoperative day
1: 68.2 % vs. 11.1 % (P < 0.001), total opioids usage in dose equivalents (DE): 1.25
vs. 3.36 DE (-62.8 %) (P=0.016), opioids usage postoperative day 1: 0.65 vs. 1.82
DE (-64.6 %) (P=0.016), opioids usage postoperative day 2: 0.24 vs. 0.75 DE (-68.4
%) (P=0.011). The length of stay in hospital was 2.35 vs. 2.93 days (n. s.), and postoperative
stay in PACU: 38.4 vs. 43.3 min (n. s.). OR time for placement of catheter and pump
is only slightly increased. No complications occurred.
Conclusion: Use of an ON~Q pain management pump could significantly reduce or even eliminate
postoperative need for opioids analgesics.
Zusammenfassung
Fragestellung: Wir untersuchten die Wirkung eines zeitlich befristet platzierten, porösen Katheters
mit kontinuierlicher Applikation eines Lokalanästhetikums (ON~Q® Pain Management System
von I-Flow-Corp., Lake Forest, CA, USA) nach Mastektomie im Vergleich zu einer Kontrollgruppe
ohne Katheter bezüglich des postoperativen Bedarfes an Opioid-Schmerzmedikation.
Material und Methode: Am Fayette Medical Center in Alabama wurde eine retrospektive Untersuchung aller
konsekutiver Mastektomien (n =49) innerhalb eines 5-Jahres-Zeitraumes von Januar 1997
bis Dezember 2001 mit statistischer Analyse des Opioid- Schmerzmittelverbrauches durchgeführt
und die beiden Gruppen: 1. ON~Q Pain Management Pump Gruppe mit kontinuierlicher 0,25
% Sensorcaine® (Bupivacain und Epinephrin) Applikation über ca. 72 h (n=22) mit 2.
der Kontrollgruppe ohne Schmerzmittelpumpe (n=27) verglichen.
Ergebnisse: Beide Gruppen wiesen bezüglich der Patientendaten keine statistisch signifikanten
Unterschiede auf. In der ON~Q-Gruppe benötigten weniger Patienten postoperativ keine
Opioide: 18,2 zu 3,7 % (P=0,1), hatten keinen Opioidbedarf nach dem 1. postoperativen
Tag: 68,2 zu 11,1 % (p < 0,001). Der gesamte Opioidverbrauch in Dosisequivalenten
(DE) war in der ON~Q Gruppe reduziert: 1,25 zu 3,36 DE (-62,8 %) (p=0,016), wie auch
der Opioidverbrauch am 1. postoperativen Tag: 0,65 zu 1,82 DE (- 64,6 %) (p=0,016)
und 2. postoperativen Tag: 0,24 zu 0,75 DE (-68,4 %) (p= 0,011). Die Länge des Krankenhausaufenthaltes
betrug 2,35 zu 2,93 Tagen (n. s.) und die Dauer der postoperativen Überwachung 38,4
zu 43,3 min (n. s.). Die OP-Zeit zur Applikation der ON~Q-Schmerzpumpe war nur geringfügig
verlängert; es gab keine Komplikationen in der Anwendung.
Schlussfolgerung: Die Verwendung des ON~Q Pain Management Systems kann den postoperativen Bedarf von
Opiaten zur Analgesie nach Mastektomie signifikant reduzieren oder sogar vermeiden.
Key words
Mastectomy - postoperative pain - pain management - breast cancer - local anaesthesia
pump
Schlüsselwörter
Mastektomie - postoperativer Schmerz - Schmerztherapie - Brustkrebs - Lokalanästhetikapumpe
References
1 Ault A. Suing for pain relief. http://www.cancerpage.com/cancernews/cancernews2724.htm
(accessed on 18.09.2002)
2
Macrae W A.
Chronic pain after surgery.
Br J Anaesth.
2001;
87
88-98
3
Tasmuth T, Kataja M, Blomqvist C, von Smitten K, Kalso E.
Treatment-related factors predisposing to chronic pain in patients with breast cancer
- a multivariate approach.
Acta Oncol.
1997;
36
625-630
4
Carpenter J S, Sloan P, Andrykowski M A, McGrath P, Sloan D, Rexford T, Kenady D.
Risk factors for pain after mastectomy/lumpectomy.
Cancer Practice.
1999;
7
66-70
5
Smith W C, Bourne D, Squair J, Phillips D O, Chambers W A.
A retrospective cohort study of post mastectomy pain syndrome.
Pain.
1999;
83
91-95
6
Kwekkeboom K.
Postmastectomy pain syndromes.
Cancer Nurs.
1996;
19
37-43
7
Shenfeld O, Eldar I, Lotan G, Avigad I, Goldwasser B.
Intraoperative irrigation with bupivacaine for analgesia after orchiopexy and herniorrhaphy
in children.
J Urol.
1995;
153
185-187
8
Tverskoy M, Cozacov C, Ayache M, Bradley EL J r, Kissin I.
Postoperative pain after inguinal herniorraphy with different types of anesthesia.
Anesth Analg.
1990;
70
29-35
9
Fong S Y, Pavy T J, Yeo S T, Paech M J, Gurrin L C.
Assessment of wound infiltration with bupivacaine in women undergoing day-case gynecological
laparoscopy.
Reg Anesth Pain Med.
2001;
26
131-136
10
Weber A, Munoz J, Garteiz D, Cueto J.
Use of subdiaphragmatic bupivacaine instillation to control postoperative pain after
laparoscopic surgery.
Surg Laparosc Endosc.
1997;
7
6-8
11
Pettersson N, Perbeck L, Hahn R G.
Efficacy of subcutaneous and topical local anesthesia for pain relief after resection
of malignant breast tumors.
Eur J Surg.
2001;
167
825-830
12
Saleh A, Fox G, Felemban A, Guerra C, Tulandi T.
Effects of local bupivacaine instillation on pain after laparoscopy.
J Am Assoc Gynecol Laparosc.
2001;
8
203-206
13
Johnson N, Onwude J L, Player J, Hicks N, Yates A, Bryce F, Tuffnell D, Jarvis G,
MacDonald H, Griffiths-Jones M. et al .
Pain after laparoscopy: an observational study and a randomized trail of local anesthetic.
J Gynecol Surg.
1994;
10
129-138
14
Yarussi A, Sands R, Edge S, Lema M J, de Leon-Casasola O A.
Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection:
a randomized, double-blind, placebo-controlled study.
Reg Anesth Pain Med.
1999;
24
142-145
15
Johansson A, Axelson J, Ingvar C, Luttropp H H, Lundberg J.
Preoperative ropivacaine infiltration in breast surgery.
Acta Anaesthesiol Scand.
2000;
44
1093-1098
16 Zimberg S E. ON~Q post-operative pain relief system in elective abdominal hysterectomy
surgery, a pilot clinical outcomes study evaluating length of stay, post-operative
pain, narcotic analgesia use and the impact on costs and adverse effects. 50th Annual
Meeting of the American Colleague of Obstetrics and Gynecology (ACOG), Los Angeles,
CA, USA, May 4th-8th 2002
17 Shahin M S, Sanders L, Sood A K. Phase II study of ON~Q Pain management System
in patients undergoing surgery for gynecologic malignancy. 30th Annual Clinical Meeting
of the Western Association of Gynecologic Oncologists, June 6th-9th 2001
18
Ashcraft E E, Baillie G M, Shafizadeh S F, McEvoy J R, Mohamed H K, Lin A, Baliga P K,
Rogers J, Rajagopalan P R, Chavin K D.
Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated
recovery.
Clin Transplantation.
2001;
15 (Suppl 6)
59-61
19
Savioe F H, Field L D, Jenkins R N, Mallon W J, Phelps 2nd R A.
The pain control infusion pump for postoperative pain control in shoulder surgery.
Arthroscopy.
2000;
16
339-342
20
Stringer N H, Rodino K L, Edwards M, Kumari N VA.
ON~Q system for managing trocar site pain after operative laparoscopy.
J Am Assoc Gynecol Laparosc.
2000;
7 (4)
552-555
21 Hebel S K, Burnham T H. Drug Facts and Comparisons. Wolver Cluiver, St. Louis,
MO, USA, 1996
22
Wilder-Smith C H, Schuler L.
Postoperative analgesia: pain by choice? The influence of patient attitudes and patient
education.
Pain.
1992;
50
257-262
23 Dine A P. Surgical site infection rates reduced with the use of continuous incisional
infusion of local anesthetic. 50th Annual Meeting of the Association of Perioperative
Registered Nurses, Chicago, IL, USA, March 23rd-27th 2003
24
Carpenter R L.
Optimizing postoperative pain management.
Am Fam Phys.
1997;
56 (3)
835-844
Dr. Volker R. Jacobs
Frauenklinik der Technischen Universität München
Ismaninger Str. 22
81675 München
Phone: 0 89/41 40-24 20
Fax: 0 89/41 40-48 31
Email: volkerjacobs@hotmail.com